Head-to-head · Cost-Efficiency Index
CoreAge Rx vs Goldspan Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CoreAge Rx
Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.
Visit CoreAge RxGoldspan Health
Shoppers who want a sublingual route priced openly beside the injection and who will count 13 charges a year rather than 12.
Visit Goldspan HealthThe verdict
CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 71. Best value in the ranking: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. Goldspan Health still earns a C — Shoppers who want a sublingual route priced openly beside the injection and who will count 13 charges a year rather than 12.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CoreAge Rx | Goldspan Health |
|---|---|---|
| Cost-Efficiency Index | 94/100 | 71/100 |
| Semaglutide / mo | $99/mo | $229 every 28 days month-to-month (13 charges a year, not 12) |
| Tirzepatide / mo | $149/mo | $299 every 28 days month-to-month (13 charges a year, not 12) |
| Semaglutide / yr (modeled) | $1,188 | $2,748 |
| Tirzepatide / yr (modeled) | $1,788 | $3,588 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #1 | #77 |
CoreAge Rx
94/100Where the value is
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
The tradeoffs
- Not the rock-bottom sticker price — 30 of the 371 priced semaglutide programs we track list a cheaper figure, though most attach a term or a step-up that CoreAge does not
- No FDA-approved brand-name option (compounded only)
Goldspan Health
71/100Where the value is
- Prices ten separate GLP-1 products openly — injection and sublingual, standard and low dose, with a B12 or a glycine base — before any account
- Each plan card itemizes what the figure buys: the clinician evaluation, the medication, injection supplies, two-day shipping and clinical-team access
- States the billing cycle honestly on the plan card and the order timeline as 28 days and four weeks
The tradeoffs
- The hero prints "/month" over a plan billed every 28 days, which is 13 charges a year rather than 12
- "Pause, delay, or cancel at any time" sits against a refund policy reading "all sales are final" and storefront terms saying an order cannot be canceled once placed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.